| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |